All Stories

  1. Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?
  2. Identification of Pseudomonas aeruginosa and airway bacterial colonization by an electronic nose in bronchiectasis
  3. A prospective international Aspergillus terreus survey: an EFISG, ISHAM and ECMM joint study
  4. Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance
  5. Epidemiology and prognosis of candidaemia in elderly patients
  6. Evaluation of the possible influence of trailing and paradoxical effects on the clinical outcome of patients with candidemia
  7. Empirical and targeted therapy of candidemia with fluconazole versus echinocandins: a propensity score–derived analysis of a population-based, multicentre prospective cohort
  8. Pseudomonas aeruginosaresistance patterns and clinical outcomes in hospitalized exacerbations of COPD
  9. Airway Mucin 2 Is Decreased in Patients with Severe Chronic Obstructive Pulmonary Disease with Bacterial Colonization
  10. Efficacy of the FilmArray blood culture identification panel for direct molecular diagnosis of infectious diseases from samples other than blood
  11. Candida tropicalis bloodstream infection: Incidence, risk factors and outcome in a population-based surveillance
  12. Multicenter Study of Epidemiological Cutoff Values and Detection of Resistance in Candida spp. to Anidulafungin, Caspofungin, and Micafungin Using the Sensititre YeastOne Colorimetric Method
  13. Evolución de la sepsis neonatal precoz por Streptococcus agalactiae en el área de Barcelona (2004-2010). Análisis de los fallos del cumplimiento del protocolo de prevención
  14. Secreted mucins and airway bacterial colonization in non-CF bronchiectasis
  15. A simple prediction score for estimating the risk of candidaemia caused by fluconazole non-susceptible strains
  16. Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: results from a population-based surveillance in Spain
  17. Implication of Candida parapsilosis FKS1 andFKS2Mutations in Reduced Echinocandin Susceptibility
  18. La infección neonatal tardía por Streptococcus agalactiae en el área de Barcelona (1996-2010)
  19. Fungemia in a Spanish hospital: the role of Candida parapsilosis over a 15-year period
  20. Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain
  21. State of the Art in the Laboratory Methods for the Diagnosis of Invasive Fungal Diseases
  22. List of Contributors
  23. Molecular Identification and Antifungal Susceptibility of Yeast Isolates Causing Fungemia Collected in a Population-Based Study in Spain in 2010 and 2011
  24. Disseminated Penicillium marneffei infection in an HIV infected patient returning from Vietnam
  25. Candidaemia detected on direct blood smears
  26. Comparison of Three Statistical Methods for Establishing Tentative Wild-Type Population and Epidemiological Cutoff Values for Echinocandins, Amphotericin B, Flucytosine, and Six Candida Species as Determined by the Colorimetric Sensititre YeastOne Method
  27. Nocardiosis pulmonar en pacientes con EPOC: características y factores pronósticos
  28. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey
  29. Prospective Multicenter Study of the Epidemiology, Molecular Identification, and Antifungal Susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis Isolated from Patients with Candidemia
  30. Nosocomial outbreak of Blastoschizomyces capitatus associated with contaminated milk in a haematological unit
  31. Recomendaciones sobre el tratamiento de la enfermedad fúngica invasiva por Aspergillus spp. y otros hongos filamentosos de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC). Actualización 2011
  32. Variación de la epidemiología de las fungemias y de la sensibilidad al fluconazol de los aislamientos de hemocultivos en los últimos 10 años en España: resultados del estudio FUNGEMYCA
  33. Prevalence ofCandida bracarensisandCandida nivariensisin a Spanish collection of yeasts: comparison of results from a reference centre and from a population-based surveillance study of candidemia
  34. Recomendaciones sobre el diagnóstico de la enfermedad fúngica invasora de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC). Actualización 2010
  35. Predictors of candidaemia caused by non-albicans Candida species: results of a population-based surveillance in Barcelona, Spain
  36. Predicting survival in adults with invasive aspergillosis during therapy for hematological malignancies or after hematopoietic stem cell transplantation: Single-center analysis and validation of the Seattle, French, and Strasbourg prognostic indexes
  37. Correlation between high-resolution computed tomography and galactomannan antigenemia in adult hematologic patients at risk for invasive aspergillosis
  38. Lower respiratory tract respiratory virus infections increase the risk of invasive aspergillosis after a reduced-intensity allogeneic hematopoietic SCT
  39. Management of endogenous cryptococcal endophthalmitis with voriconazole
  40. Ability of the new VITEK® 2Neisseria-Haemophilus card for the identification of fastidious organisms
  41. Prevalence and Susceptibility Profile of Candida metapsilosis and Candida orthopsilosis: Results from Population-Based Surveillance of Candidemia in Spain
  42. Clinical and microbiological features of nocardiosis 1997-2003
  43. Treatment of protothecosis with voriconazole
  44. Erythematous Papules on the Leg—Quiz Case
  45. Epidemiology, Risk Factors, and Prognosis of Candida parapsilosis Bloodstream Infections: Case-Control Population-Based Surveillance Study of Patients in Barcelona, Spain, from 2002 to 2003
  46. Candidemia in Neonatal Intensive Care Units
  47. Characterisation of fluoroquinolone-resistant clinical isolates of Streptococcus pyogenes in Barcelona, Spain
  48. Epidemiology and Predictors of Mortality in Cases of Candida Bloodstream Infection: Results from Population-Based Surveillance, Barcelona, Spain, from 2002 to 2003
  49. Cutaneous alternariosis in transplant recipients: Clinicopathologic review of 9 cases
  50. In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population-based active surveillance programme, Barcelona, Spain, 2002–2003
  51. Invasive disease caused by Haemophilus influenzae: the sensitivity of statutory reporting
  52. Antibiotic susceptibility of strains isolated from patients with meningococcal disease and their household contacts in Catalonia (Spain). May 1998–April 1999
  53. Declive de la incidencia de la sepsis perinatal por estreptococo del grupo B (Barcelona 1994-2001). Relación con las políticas profilácticas
  54. Prevalence of Neisseria meningitidis carriers in the school population of Catalonia, Spain
  55. Opportunistic Infections: An Overview
  56. Pacemaker Infection by Brucella melitensis: A Rare Cause of Relapsing Brucellosis
  57. Prevalence of Haemophilus influenzae Carriers in the Catalan Preschool Population
  58. Haemophilus influenzae meningitis in Catalonia, Spain: epidemiology and bacteriologic characteristics
  59. Microbiological Quality Control Study of "All-In-One" Total Parenteral Nutrition Admixtures
  60. Factores pronósticos de la aspergilosis pulmonar invasiva en pacientes con neumopatía crónica
  61. Morbidity Associated with Long‐Term Use of Totally Implantable Ports in Patients with AIDS
  62. Correlation between serotype and in-vitro antibiotic susceptibility of pneumococci isolated in Saudi Arabia
  63. Pseudomonas aeruginosa bronchopulmonary infection in patients with AIDS, with emphasis on relapsing infection
  64. Remission of Relapsing Pseudomonas aeruginosa Bronchopulmonary Infection Following Antiretroviral Therapy
  65. RecurrentPseudomonas aeruginosaPneumonia in Ventilated Patients
  66. Early microbiologic diagnosis of spontaneous bacterial peritonitis with BacT/ALERT
  67. Prevention of Perinatal Group B Streptococcal Disease in Europe:(Group of Microbiologists for the Study and Prevention of Perinatal Group B Streptococcal Disease, in the Area of Barcelona)
  68. Emergence of different resistance mechanisms inPseudomonas aeruginosa in a patient treated with imipenem
  69. Escherichia coli capsular polysaccharide and spontaneous bacterial peritonitis in cirrhosis
  70. Escherichia Coli capsular polysaccharide and spontaneous bacterial peritonitis in cirrhosis
  71. Ultrastructural localization of major hydatid fluid antigens in brood capsules and protoscoleces of Echinococcus granulosus of human origin
  72. Neisseriaceae isolated from unusual sites
  73. Simultaneous Shigella and Salmonella Septicemia in an AIDS patient
  74. Echinococcus granulosus: Antigen characterization by chemical treatment and enzymatic deglycosylation
  75. Immunochemical localization of major hydatid fluid antigens in protoscoleces and cysts of Echinococcus granulosus from human origin